The efficacy of pericapsular nerve group block for reducing pain and opioid consumption after total hip arthroplasty: a systematic review and meta-analysis

Table 1 The details of trial characteristics

Author, year	Country	Design	Study	No. of patients		Gender (male)		Age		Anesthesia method	Treatment		Outcome
Author, year	Country	Design	Study	PENG	Control	PENG	Control	PENG	Control	Anesthesia method	PENG	Control	Outcome
Kukreja, 2023	USA	RCT	THA	56	56	26	22	59	62	Spinal anesthesia	bupivacaine 0.5% (25 ml)	no block	1, 2, 3, 4, 6, 7
Hu, 2023	China	RCT	THA	45	45	21	23	59	56	General anesthesia	Ropivacaine (20 mL, 0.5%) containing 1:200,000 epinephrine	20 mL 0.9% saline	1, 2, 3, 4, 5, 6, 7, 8
Domagalska, 2023	Poland	RCT	THA	239	237	140	122	66	66	Spinal anesthesia	20 mL of 0.5% ropivacaine	20 mL of 0.9% NaCl	3, 4, 5, 6, 7
Zheng,2022	China	RCT	THA	34	36	12	15	63	64	General anesthesia	20 mL 0.5% ropivacaine	20 mL 0.9% saline	1, 2, 3, 4, 7, 8
Pascarella,2021	Italy	RCT	THA	30	30	16	17	66	67	Spinal anesthesia	20 ml of ropivacaine 0.375%	no block	5, 7, 8

1, Pain score in PACU. 2, Pain score at 6 h. 3, Pain score at 24 h. 4, Pain score at 48 h. 5, Time to first opioid. 6, Opioid consumption at 24 h. 7, Opioid consumption at 24 h. 8, Incidence of complications

ISSN: 1749-799X